RECENT NEWS
Benzinga  Aug 26  Comment 
Great Basin Scientific, Inc. (NASDAQ:GBSN; GBSNU), a molecular diagnostics company, confirmed today that, the Company's publicly traded unit (NASDAQ: GBSNU) has separated into its component parts of eight Series C Warrants and one share of Series...
Benzinga  Aug 25  Comment 
Burning Rock and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock will develop advanced clinical applications for molecular diagnostics in oncology based on Illumina's...
Benzinga  Aug 14  Comment 
In a report published Friday, Leerink analyst Dan Leonard initiated coverage of TrovaGene, Inc. (NASDAQ: TROV) with an Outperform rating and price target of $9. According to the Leerink report, "TROV is an early stage pure play in the cancer...
GenEng News  Jul 31  Comment 
Molecular pathology attempts to describe and understand the origins and mechanisms of disease by evaluating the molecular content of patient samples. Increasingly, “molecular content” is being seen as an intricate, interconnected whole, a...
GenEng News  Jul 14  Comment 
OpGen said today it agreed to acquire molecular diagnostics developer AdvanDx for an undisclosed price. The deal adds AdvanDx’s FDA-approved and CE marked rapid molecular tests to OpGen’s tools designed to fight multi-drug resistant...
GenEng News  Jul 7  Comment 
As described by the National Institutes of Health (NIH), point-of-care (POC) instruments combine multiple analytical functions into self-contained, portable devices that can be used by nonspecialists to detect and diagnose disease. They can also...
Benzinga  Jun 8  Comment 
Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that clinical data featuring its Precision Cancer MonitoringSM platform will be presented at the 2015 Cancer Markers and Liquid Biopsies conference in...
Benzinga  Jun 3  Comment 
Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, today announced that it has entered into a clinical collaboration with Sarah Cannon...




 

Molecular diagnostics is a new method of detecting a disease by analyzing a patient's DNA

Companies in the Molecular Diagnostics Industry (4)

  • M
  • Company icon
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki